A detailed history of Jgp Global Gestao De Recursos Ltda. transactions in Amgen Inc stock. As of the latest transaction made, Jgp Global Gestao De Recursos Ltda. holds 1,362 shares of AMGN stock, worth $379,671. This represents 0.86% of its overall portfolio holdings.

Number of Shares
1,362
Previous 1,048 29.96%
Holding current value
$379,671
Previous $327,000 33.94%
% of portfolio
0.86%
Previous 0.56%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$309.38 - $337.38 $97,145 - $105,937
314 Added 29.96%
1,362 $438,000
Q2 2024

Aug 02, 2024

SELL
$262.75 - $319.31 $3,153 - $3,831
-12 Reduced 1.13%
1,048 $327,000
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $285,002 - $344,033
1,060 New
1,060 $301,000
Q1 2022

May 05, 2022

SELL
$219.27 - $242.57 $228,917 - $253,243
-1,044 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$198.88 - $227.6 $397 - $455
-2 Reduced 0.19%
1,044 $235,000
Q3 2021

Nov 04, 2021

SELL
$212.27 - $248.7 $80,874 - $94,754
-381 Reduced 26.7%
1,046 $222,000
Q2 2021

Aug 09, 2021

BUY
$233.58 - $259.14 $934 - $1,036
4 Added 0.28%
1,427 $348,000
Q1 2021

May 11, 2021

SELL
$221.91 - $258.6 $185,516 - $216,189
-836 Reduced 37.01%
1,423 $354,000
Q4 2020

Jan 27, 2021

SELL
$216.38 - $257.67 $7,573 - $9,018
-35 Reduced 1.53%
2,259 $519,000
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $32,381 - $36,011
-138 Reduced 5.67%
2,294 $583,000
Q1 2020

May 07, 2020

BUY
$182.24 - $241.7 $217,230 - $288,106
1,192 Added 96.13%
2,432 $493,000
Q4 2019

Jan 24, 2020

BUY
$189.21 - $243.2 $2,838 - $3,648
15 Added 1.22%
1,240 $299,000
Q3 2019

Oct 29, 2019

BUY
$174.11 - $208.62 $4,178 - $5,006
24 Added 2.0%
1,225 $237,000
Q2 2019

Jul 19, 2019

BUY
$166.7 - $195.41 $200,206 - $234,687
1,201 New
1,201 $221,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Jgp Global Gestao De Recursos Ltda. Portfolio

Follow Jgp Global Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.